Dr. Al-Aly is the Chief of Research and Development Service at the VA Saint Louis Health Care System.
He is a physician scientist with broad research interests including public health, global health, environmental epidemiology, and pharmacoepidemiology.
He leads several research initiatives aimed at developing a deep understanding of the short- and long-term effects of COVID 19 on health outcomes.
He has published extensively in several major journals including BMJ, JAMA, Lancet, NEJM, Nature, and others. His work is frequently featured in major national and international media outlets including New York Times, CNN, BBC, NPR, the Guardian, Bloomberg, The New Yorker, the Atlantic, and several others.
According to Google Scholar, his work has been cited more than 198,000 times
Dr. Al-Aly was also awarded the U.S. Department of Veterans Affairs Secretary’s Award — the highest VA award — for outstanding contributions to research in 2023.
Dr. Ziyad Al-Aly, has been featured in the TIME100 Health – TIME’s list of 100 individuals who most influenced global health in 2024.
According to TIME, the list “recognizes the impact, innovation, and achievement of the world’s most influential individuals in health”.
- View Dr. Al-Aly’s profile here: TIME100 Health: Ziyad Al-Aly | TIME
- The full list is here: TIME100 Most Influential People in Health | TIME
View Dr. Al-Aly’s other research profiles on Washington University in St. Louis and ORCID
Dr. Al-Aly is also the Director of the Clinical Epidemiology Center at the VA St. Louis Healthcare System. Learn more about the CEC and the research they conduct here.